Withanoside IV

Category
terpenoid
Routes
Oral (PO)
Formula
C40H62O15
Molecular Weight
782.96 g/mol
PubChem CID
71312551
Aliases
Withanoside-IV

Pharmacological Mechanism

Glycosylated withanolide — aglycone is withanolide-A linked to a sugar moiety. The dominant glycowithanolide in standardized "glycoside-rich" ashwagandha extracts (Shoden). Preclinical models show neurite-outgrowth and anxiolytic activity (likely after gut/hepatic hydrolysis to free withanolide-A). The clinical effect rationale of glycoside-standardized extracts is sustained downstream aglycone exposure.

Dosing Guidelines

Pathways It Modulates

Target Organ Systems

Notes

Glycoside of withanolide-A; dominant glycowithanolide in Shoden-standardized extracts. PK not separately characterized in humans; effect likely transduced through aglycone after gut hydrolysis.

Chemical Structure & Identifiers